Matthews, D A, Lane, T J, Manu, P · Southern medical journal · 1991 · DOI
This study tested whether Epstein-Barr virus (EBV) antibodies in the blood can help identify ME/CFS patients. Researchers compared 35 fatigued patients with signs of chronic EBV infection to 35 matched fatigued patients without these signs. They found very few differences between the groups, suggesting that EBV antibody testing is not particularly useful for diagnosing or understanding chronic fatigue.
This study challenges the hypothesis that EBV reactivation drives ME/CFS pathology, suggesting that EBV antibody testing alone cannot stratify or diagnose chronic fatigue syndrome. Understanding which infections are clinically relevant to ME/CFS versus coincidental findings helps guide research priorities and clinical evaluation strategies.
This study does not prove that EBV plays no role in ME/CFS pathogenesis—only that antibody patterns on serologic testing are not clinically discriminatory. The absence of detected differences does not rule out EBV-specific immune dysfunction, viral persistence, or contributions to disease in subset populations. The cross-sectional design cannot establish causation or temporal relationships.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →